Jiangsu Nanfang Medical Co., Ltd. (SHA:603880)
China
· Delayed Price · Currency is CNY 7.12
+0.35 (5.17%)
Mar 10, 2026, 3:00 PM CST
Jiangsu Nanfang Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,957 | 1,257 | 1,489 | 1,813 | 2,094 | 2,855 | Upgrade
|
| Market Cap Growth | 39.59% | -15.54% | -17.90% | -13.41% | -26.66% | 44.53% | Upgrade
|
| Enterprise Value | 2,375 | 1,692 | 1,917 | 2,122 | 2,243 | 2,696 | Upgrade
|
| Last Close Price | 6.77 | 4.35 | 5.09 | 6.20 | 7.16 | 9.61 | Upgrade
|
| PE Ratio | - | - | - | - | - | 29.12 | Upgrade
|
| PS Ratio | 3.29 | 2.09 | 2.48 | 3.33 | 3.97 | 2.66 | Upgrade
|
| PB Ratio | 7.54 | 4.42 | 3.14 | 2.92 | 3.29 | 4.07 | Upgrade
|
| P/TBV Ratio | 9.18 | 5.31 | 3.47 | 3.15 | 3.52 | 4.33 | Upgrade
|
| P/FCF Ratio | 26.41 | 40.67 | - | - | - | 92.61 | Upgrade
|
| P/OCF Ratio | 23.38 | 19.86 | 95.99 | 57.98 | - | 18.53 | Upgrade
|
| EV/Sales Ratio | 3.99 | 2.81 | 3.19 | 3.89 | 4.25 | 2.51 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 142.77 | 174.34 | 17.20 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 19.76 | Upgrade
|
| EV/FCF Ratio | 32.05 | 54.74 | - | - | - | 87.45 | Upgrade
|
| Debt / Equity Ratio | 1.77 | 1.75 | 0.99 | 0.76 | 0.56 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 31.04 | 27.15 | 1.13 | Upgrade
|
| Debt / FCF Ratio | 6.22 | 16.07 | - | - | - | 5.76 | Upgrade
|
| Net Debt / Equity Ratio | 1.59 | 1.49 | 0.74 | 0.52 | 0.28 | -0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.03 | -4.71 | -9.62 | 21.83 | 14.07 | -0.94 | Upgrade
|
| Net Debt / FCF Ratio | 5.57 | 13.73 | -6.93 | -2.82 | -0.61 | -4.79 | Upgrade
|
| Asset Turnover | 0.53 | 0.52 | 0.44 | 0.41 | 0.46 | 1.10 | Upgrade
|
| Inventory Turnover | 2.64 | 2.77 | 2.04 | 1.89 | 2.58 | 6.10 | Upgrade
|
| Quick Ratio | 0.25 | 0.27 | 0.36 | 0.46 | 0.56 | 1.35 | Upgrade
|
| Current Ratio | 0.52 | 0.54 | 0.72 | 0.84 | 1.00 | 1.79 | Upgrade
|
| Return on Equity (ROE) | -56.11% | -50.22% | -26.88% | -2.38% | -3.45% | 15.50% | Upgrade
|
| Return on Assets (ROA) | -8.31% | -7.50% | -4.15% | -1.22% | -0.87% | 8.78% | Upgrade
|
| Return on Invested Capital (ROIC) | -21.93% | -18.27% | -10.25% | -2.99% | -2.34% | 23.72% | Upgrade
|
| Return on Capital Employed (ROCE) | -53.90% | -44.30% | -18.70% | -4.10% | -2.50% | 19.10% | Upgrade
|
| Earnings Yield | -10.34% | -15.17% | -9.90% | -0.81% | -1.09% | 3.44% | Upgrade
|
| FCF Yield | 3.79% | 2.46% | -3.40% | -6.33% | -14.13% | 1.08% | Upgrade
|
| Dividend Yield | - | - | - | - | - | 1.20% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 16.14% | Upgrade
|
| Buyback Yield / Dilution | -0.34% | -1.48% | 1.34% | -2.97% | 0.60% | -2.66% | Upgrade
|
| Total Shareholder Return | -0.34% | -1.48% | 1.34% | -2.97% | 0.60% | -1.46% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.